Ana Solodkin

Has worked for more than 25 years to discover biomarkers associated with clinical predictions in neurodegenerative diseases, such as Alzheimer’s and spinocerebellar ataxias, in the hope of finding therapeutic interventions. She has conceptualized and developed analytical tools, from anatomical neuropathology to computational modeling embodied by The Virtual Brain.